A Day Up For UroGen Pharma Ltd.
Fri, Jun 06, 2025 at 07:39 PM
UroGen Pharma Ltd. (URGN:NASDAQ) soared at $7.37, representing a gain of 43.4%. On Fri, Jun 06, 2025, URGN:NASDAQ touched a New 2-Week High of $7.37. The stock got featured on our News Catalysts scanner on Fri, Jun 06, 2025 at 10:45 AM in the 'PRIVATE PLACEMENT' category. From Fri, May 23, 2025, the stock recorded 66.67% Up Days and 70.00% Green Days
About UroGen Pharma Ltd. (URGN:NASDAQ)
UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.
Top 10 Gainers:
- Know Labs, Inc. (KNW:NYSEMKT), 205.88%
- Phathom Pharmaceuticals, Inc. (PHAT:NASDAQ), 90.19%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 55.97%
- Eyenovia, Inc. (EYEN:NASDAQ), 55.41%
- Pheton Holdings Ltd (PTHL:NASDAQ), 51.69%
- WEBUY GLOBAL LTD. (WBUY:NASDAQ), 50.42%
- Borealis Foods Inc. (BRLS:NASDAQ), 50.14%
- Diginex Limited (DGNX:NASDAQ), 48.24%
- Bluejay Diagnostics, Inc. (BJDX:NASDAQ), 48.03%
- UroGen Pharma Ltd. (URGN:NASDAQ), 43.39%